Potential Benefits, Risks, and Ethical Dilemmas
Joan and Nir discuss the potential benefits and risks of using drugs like Everlimus, Rapamycin, and Metformin in patients with severe influenza and COVID-19. They emphasize the importance of generating data through clinical trials to determine the true impact of these drugs. Additionally, they touch on the ethical dilemma of making decisions based on limited evidence during a pandemic.In this clip
From this podcast
The Peter Attia Drive Podcast
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Related Questions